Perrigo Has First US Approval For OTC Omeprazole Mini-Capsule

Capsule is 70% smaller than tablets of omeprazole currently available in Prilosec OTC and generic equivalents, including formulations Perrigo provides for its private label and store brand customers.

• Source: Shutterstock

Perrigo Company PLC marks another first in its transition to being entirely consumer health-focused with approval in the US of proton pump inhibitor omeprazole magnesium 20-mg delayed-released in mini-capsule format.

The capsule is 70% smaller than tablets of omeprazole currently available in the Prilosec OTC brand marketed by Procter...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Health